uniQure says its one-time gene therapy slowed Huntington’s disease by 75% over three years
techkahwa.net | 25 September 2025 Biotech company uniQure reported on 24 September that its experimental gene therapy AMT-130 produced a statistically significant 75% slowing of Huntington’s disease progression at 36 months in patients who received the high dose. These are topline results announced by the company, not yet peer reviewed, and the treatment is not … Read more